Recent Research on Psilocybin Gives Mixed Results

Compass Pathways published the long awaited results of its phase 2 clinical trial for the treatment of depression with psilocybin–assisted psychotherapy in the New England Journal of Medicine.

Psilocybin showed rapid antidepressant effects for most patients, but only 1 in 5 participants showed significant improvement at 12 weeks.

Read more

Psychedelics and Mental Health: Recent Research

Psychedelic drugs can induce mind-altering states affecting perception, thought and sensory input.

They have historically been known for their recreational use and do not have nationwide legal approval.

However, psychedelic drugs are also increasingly being studied for their medical benefits (particularly with regard to mental health).

Learn more below about how certain psychedelics can—and cannot—be used for mental wellness.

Read more